The Missing Link Between Belly Fat
    and Heart Disease?

    By now, everyone knows that overweight
    people face a higher risk of heart attacks,
    strokes and other problems that arise
    from clogged, hardened arteries. And        
    people who carry their extra weight
    around their waist – giving them a “beer
    belly” or an “apple” shape -- have the
    highest risk of all.

    But despite the impact on human health,
    the reasons behind this connection bet-
    ween heart disease and belly fat – also known as visceral fat -- have eluded
    scientists. Now, a new study in mice gives the first direct evidence of why this link
    might exist – and a tantalizing look at how it might be broken.

    In a paper published online in the journal Circulation, a team of University of
    Michigan Cardiovascular Center scientists reports direct evidence of a link
    between inflammation around the cells of visceral fat deposits, and the artery-
    hardening process of atherosclerosis.

    The researchers also show that a medication often given to people with diabetes
    can be used to calm that inflammation, and protect against further artery damage.

    Although the scientists caution that it’s far too early to apply their findings to
    humans with belly fat, they hope that further research in animals and people will
    reveal more about how this dangerous link comes about, why it begins, how it
    can be reversed, and perhaps how it can be diagnosed at an early stage through
    blood tests.

    Until then, the best advice for overweight people who want to reduce their chance
    of a heart attack or stroke remains the same: Work on losing your belly fat, and
    your other excess body weight, through a balanced, healthy diet and regular
    exercise.

    The research team is led by Daniel Eitzman, M.D., a cardiologist, laboratory
    scientist and associate professor in the Division of Cardiovascular Medicine at
    the U-M Medical School and the VA Ann Arbor Healthcare System.

    The discovery came partly by chance. He and his colleagues had been studying
    mice that lack the gene for leptin, a hormone generated by fat cells that plays a
    role in appetite and metabolism as well as reproduction. In an effort to get these
    obese mice to produce some leptin, the team developed a technique to
    transplant clusters of fat cells from normal mice of the same strain, into the
    leptin-deficient mice.

    The result surprised them. “In addition to producing leptin and preventing
    obesity, the fat transplants became inflamed, attracting immune cells called
    macrophages,” Eitzman explains. “Since the mice were genetically identical
    except for leptin, this shouldn’t have happened. But the inflammation was there,
    and it was chronic.”

    The inflammation occurred around individual fat cells, or adipocytes. Further
    tests showed it was regulated by the same factors that regulate the inflammation
    that other researchers have seen in the naturally occurring fat deposits of obese
    mice – specifically a chemokine called MCP-1.

    But because the fat was transplanted, the inflammation could be attributed
    directly to the fat, and not to overfeeding of the mice, or the metabolic problems
    that overfeeding and obesity bring, such as diabetes.

    Armed with this discovery, the researchers set out to see what was causing
    inflammation to occur, and what implications it had. The team included
    postdoctoral fellow Miina Öhman, M.D., Ph.D., U-M professor Daniel Lawrence,
    Ph.D., and members of the Eitzman and Lawrence laboratory teams.

    They were especially interested to see if there might be any link between the
    inflammation and atherosclerosis – the formal name for the process by which
    blood vessels become stiff, narrowed and lined with plaque formations that can
    trigger the development of blood clots.

    This process, which occurs throughout the body, sets the stage for most heart
    attacks and strokes. Scientists and clinicians now realize that it is based on
    inflammation – the abnormal reaction of the body’s immune system to its own
    tissue — and in the damage that immune-system cells and molecules can inflict.

    Since normal mice don’t develop atherosclerosis, the team had to turn to a strain
    that had been developed to be especially prone to high cholesterol and
    hardened arteries. These ApoE-negative mice, as they are called, were divided
    into three groups: two that received fat transplants from normal mice, and one
    that did not, but that had the same operation that would be used to implant the fat
    in other mice.

    Some of the fat-transplant ApoE-negative mice received transplants of visceral
    fat, which forms in the belly around the major organs, while others received
    transplants of subcutaneous fat – the type that’s found just under the skin
    throughout the body.

    Sure enough, the mice that received the visceral fat transplants developed
    atherosclerosis at a much-accelerated rate, and experienced the same type of
    inflammation as the leptin-deficient mice had. Meanwhile, those that received
    subcutaneous fat did not experience an increase in atherosclerosis despite
    having increased inflammation. The mice that had the “sham” operations
    developed neither inflammation nor increased atherosclerosis.

    “There appeared to be an interaction between the macrophages causing the
    inflammation in the visceral fat, and the process of atherosclerosis,” says
    Eitzman, who notes that blood vessels far from the site of the fat transplant
    developed increased atherosclerosis.

    Finally, the team attempted to calm the inflammation and curb the
    atherosclerosis by treating the mice with pioglitazone – a member of the class of
    drugs called thiazolidinediones or TZDs that are often used to treat diabetes.
    While TZD drugs have an impact on metabolism, which makes them useful in
    diabetes, they also have been discovered to have an anti-inflammatory effect.

    And in fact, the drug reduced both the concentration of macrophages and MCP-1,
    and atherosclerosis, in those mice that received transplants of visceral fat. But
    the drug had no effect in the other mice.

    Now that they have demonstrated the linkage between belly fat, inflammation and
    hardened arteries, and a potential mechanism for reversing the phenomenon,
    the team is working on new pieces of the puzzle. Specifically, they’re looking for
    the factors that might trigger macrophages to invade the area and bring on
    inflammation, and for blood-borne molecules called biomarkers that might be
    used as a way to identify early warning signs of atherosclerosis. They’ll also look
    at other classes of drugs to see if they might have a protective effect, because
    TZD drugs act on many systems and cause some side effects.

    In addition to Eitzman, Öhman and Lawrence, the team includes former research
    associate Yuechen Shen, M.D., former U-M undergraduate Chinyere Obimba, B.
    S., now a Harvard Medical School student; former U-M undergraduate and
    current U-M medical student Andrew P. Wright, B.S.; and Mark Warnock, B.S. The
    research was funded by the National Heart, Lung and Blood Institute.
Normal mice (left) and obese mice
without the gene for leptin (right) were
essential to the U-M discovery that
inflammation in visceral fat is linked to
atherosclerosis.
(Picture courtesy of
University of Michigan Health System)
Want to Lose Weight? Eat a Big Breakfast!
Study says eating a big breakfast helps in weight loss.

The Best Abdominal Exercises
Researchers look at the top 13 exercises for great abs.

Watch What You Eat
If you're serious about losing weight, you've got to watch
what you eat.

Calculating Your Ideal Body Weight
Do you have an ideal body weight? Find out using this
simple calculator.

The Best Time to Exercise
It's not only how but also when that is important when
following a weight reduction or fitness program.
Pot Bellies Linked to Heart Disease

Excess Body Fat Causes Cancer

Brain Chemical Blocks Weight Gain

Weight Maintenance Helps Prevent Cancer

Large Waist Triples Risk of Dementia

A New Way to Combat Weight Gain

'Most Effective Weight Loss Diet'





New Hope for Prostate Cancer Victims

The Power of Juice

Daytime Dozing Linked to High Stroke Risk

This Diet Reduces Risk of Memory Problems

Naps Are Good for Your Heart

Build Stronger Bones

Top 10 Nutrition Myths Debunked

For Complete List of Stories, Click Here
« Back to Stomach Weight Loss Page
    MORE WEIGHT LOSS STORIES
    OTHER HEALTH STORIES
    OTHER WEIGHT LOSS STORIES
« Back to Stomach Weight Loss Page